Expression of ghrelin gene in peripheral blood mononuclear cells and plasma ghrelin concentrations in patients with metabolic syndrome

European Journal of Endocrinology

Volumn 158, Issue 4, 2008, Pages 499-510

  Mager, Ursula ^a   Kolehmainen, Marjukka ^a   de Mello, Vanessa D F ^a,b   Schwab, Ursula ^a   Laaksonen, David E ^a   Rauramaa, Rainer ^a   Gylling, Helena ^a   Atalay, Mustafa ^a   Pulkkinen, Leena ^a   Uusitupa, Matti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYTOSINE; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR 1B; GUANOSINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; EXERCISE; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN METABOLISM; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROENVIRONMENT; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; BLOOD; GENETICS; IMMUNOLOGY; KINESIOTHERAPY; METABOLISM; METHODOLOGY; MIDDLE AGED; MONONUCLEAR CELL; MORPHOMETRICS; OSMOLARITY; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AUTOCRINE COMMUNICATION; BODY WEIGHTS AND MEASURES; EXERCISE THERAPY; FEMALE; GENE EXPRESSION; GENOTYPE; GHRELIN; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSMOLAR CONCENTRATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GHRELIN; RESEARCH DESIGN; WEIGHT LOSS;

EID: 41749125483     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0862     Document Type: Article

References (68)

1. Higgins SC, Gueorguiev M & Korbonits M. Ghrelin, the peripheral hunger hormone. Annals of Medicine 2007 39 116-136.
2. Kojima M & Kangawa K. Ghrelin: structure and function. Physiological Reviews 2005 85 495-522.
3. Saad M, Bernaba B, Hwu CM, Jinagouda S, Fahmi S, Kogosov E & Boyadjian R. Insulin regulates plasma ghrelin concentration. Journal of Clinical Endocrinology and Metabolism 2002 87 3997-4000.
4. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV & Sherwin RS. The influence of insulin on circulating ghrelin. American Journal of Physiology. Endocrinology and Metabolism 2003 284 E313-E316.
5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660.
6. Ukkola O, Ravussin E, Jacobson P, Perusse L, Rankinen T, Tschöp M, Heiman ML, Leon AS, Rao DC, Skinner JS, Wilmore JH, Sjöström L & Bouchard C. Role of ghrelin polymorphisms in obesity based on three different studies. Obesity Research 2002 10 782-791.
7. Ukkola O, Ravussin E, Jacobson P, Snyder EE, Chagnon M, Sjöström L & Bouchard C. Mutations in the preproghrelin /ghrelin gene associated with obesity in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 3996-3999.
8. Kuzuya M, Ando F, Iguchi A & Shimokata H. Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort. International Journal of Obesity 2006 30 1609-1614.
9. Tang NP, Wang LS, Yang L, Gut HJ, Zhu HJ, Zhou B, Sun QM, Cong RH & Wang B. Preproghrelin Leu72Met polymorphism in Chinese subjects with coronary artery disease and controls. Clinica Chimica Acta 2008 387 42-47.
10. Mager U, Kolehmaimen M, Lindström J, Eriksson JG, Valle TT, Hömälönen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto JO, Pulkkinen L & Uusitupa MI. Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance. American Journal of Hypertension 2006 19 920-926.
11. Kim SY, Jo DS, Hwang PH, Park JR, Park SK, Yi HK & Lee DY. Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism 2006 55 366-370.
12. Mager U, Lindi V, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Pulkkinen L & Uusitupa M. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study. Diabetic Medicine 2006 23 685-689.
13. Korbonits M, Gueorguiev M, O'Grady E, Lecoeur C, Swan DC, Mein CA, Weill J, Grossman AB & Froguel P. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. Journal of Clinical Endocrinology and Metabolism 2002 87 4005-4008.
14. Pöykkö SM, Ukkola O, Kauma H, Savolainen MJ & Kesäiniemi YA. Ghrelin Arg5lGln mutation is a risk factor for type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia 2003 46 455-458.
15. Steinle NI, Pollin TI, O'Connell JR, Mitchell BD & Shuldiner AR. Variants in the ghrelin gene are associated with metabolic syndrome in the Old Order Amish. Journal of Clinical Endocrinology and Metabolism 2005 90 6672-6677.
16. Bing C, Ambye L, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad S & Urhammer SA. Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabetic Medicine 2005 22 1157-1160.
17. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB & Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology and Metabolism 2002 87 2988.
18. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K & Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells. B cells, and neutrophils. Journal of Clinical Endocrinology and Metabolism 2001 86 4284-4291.
19. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Ir & Taub DD. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. Journal of Clinical Investigation 2004 114 57-66.
20. Howard AD, Feighner SD, Cully DF. Arena JP, Liberator PA, Rosenblum CI. Hamelin M, Hreniuk DL. Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY. Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA. Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG & Van der Ploeg LH. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996 273 974-977.
21. van der Lely AJ, Tschöp M, Heiman ML & Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews 2004 25 426-457.
22. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E & Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001 50 707-709.
23. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M. Nozoe S. Hosoda H, Kangawa K & Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology and Metabolism 2002 87 240-244.
24. Tentolouris N, Kokkinos A, Tsigos C, Kyriaki D, Doupis J. Raptis SA & Katsilambros N. Differential effects of high-fat and high-carbohydrate content isoenergetic meals on plasma active ghrelin concentrations in lean and obese women. Hormone and Metabolic Research 2004 36 559-563.
25. Tesauro M, Schinzari F, Iantorno M, Rizza S, Melina D, Lauro D & Cardillo C. Ghrelin improves endothelial function in patients with metabotic syndrome. Circulation 2005 112 2986-2992.
26. Chu MC, Cosper P, Orin F, Carmina E & Lobo RA. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. American Journal of Obstetrics and Gynecology 2006 194 100-104.
27. McLaughlin T, Abbasi F, Lamendola C, Frayo RS & Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. Journal of Clinical Endocrinology and Metabolism 2004 89 1630-1635.
28. Barazzoni R, Zanetti M, Ferreira C, Vinci P, Pirulli A, Mucci M, Dore F, Fonda M, Ciocchi B. Cattin L & Guarnieri G. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 3935-3940.
29. St-Pierre DH, Karelis AD, Coderre L, Malita F, Fontaine J, Mignault D, Brochu M, Bastard JP, Cianflone K, Doucet E, Imbeault P & Rabasa-Lhoret R. Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2007 92 264-269.
30. Zahorska-Markiewicz B, Mizia-Stec K, Olszanecka-Glinianowicz M & Janowska J. Effect of weight reduction on serum ghrelin and TNF-α concentrations in obese women. European Journal of Internal Medicine 2004 15 172-175.
31. Langenberg C, Bergstrom J, Laughlin GA & Barrett-Connor E. Ghrelin and the metabolic syndrome in older adults. Journal of Clinical Endocrinology and Metabolism 2005 90 6448-6453.
32. Ukkola O, Pöykkö SM & Kesäniemi YA. Low plasma ghrelin concentration is an indicator of the metabolic syndrome. Annals of Medicine 2006 38 274-279.
33. Katsuki A, Urakawa H, Gabazza EC, Murashima S, Nakatani K, Togashi K, Yano Y, Adachi Y & Sumida Y. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. European Journal of Endocrinology 2004 151 573-577.
34. Purnell JQ, Weigle DS, Breen P & Cummings DE. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol. but not with gender, menopausal status, or cortisol levels in humans. Journal of Clinical Endocrinology and Metabolism 2003 88 5747-5752.
35. Park HS, Lee KU. Kim YS & Park CY. Relationships between fasting plasma ghrelin levels and metabolic parameters in children and adolescents. Metabolism 2005 54 925-929.
36. Pöykkö SM, Kellokoski E, Horkko S, Kauma H, Kesäniemi YA & Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003 52 2546-2553.
37. Fagerberg B, Hulten LM & Hulthe J. Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study. Metabolism 2003 52 1460-1463.
38. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK. Dellinger EP & Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine 2002 346 1623-1630.
39. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS & Jorgensen JO. Weight loss increases circulating levels of ghrelin in human obesity. Clinical Endocrinology 2002 56 203-206.
40. Boden G, Sargrad K, Homko C, Mozzoli M & Stein TP. Effect of a low-carbohydrate diet on appetite. blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Annals of Internal Medicine 2005 142 403-411.
41. Purnell JQ, Cummings D & Weigle DS. Changes in 24-h area-under-the-curve ghrelin values following diet-induced weight loss are associated with toss of fat-free mass, but not with changes in fat mass, insulin levels or insulin sensitivity. International Journal of Obesity 2007 31 385-389.
42. Hayes MR, Miller CK, Ulbrecht JS, Manger JL, Parker-Klees L, Gutschall MD, Mitchell DC, Smiciklas-Wright H & Covasa M. A carbohydrate-restricted diet alters gut peptides and adiposity signals in men and women with metabolic syndrome. Journal of Nutrition 2007 137 1944-1950.
43. Santosa S, Demonty I, Lichtenstein AH, Cianflone K & Jones PJ. An investigation of hormone and lipid associations after weight loss in women. Journal of the American College of Nutrition 2007 26 250-258.
44. Weigle DS, Cummings DE, Newby PD, Breen PA, Frayo RS, Matthys CC, Callahan HS & Purnell JQ. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. Journal of Clinical Endocrinology and Metabolism 2003 88 1577-1586.
45. Reinehr T, Roth CL, Alexy U, Kersting M, Kiess W & Andler W. Ghrelin levels before and after reduction of overweight due to a low-fat high-carbohydrate diet in obese children and adolescents. International Journal of Obesity 2005 29 362-368.
46. Reinehr T, de Sousa G & Roth CL. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clinical Endocrinology 2007 68 304-310.
47. Garcia JM, Iyer D, Poston WS. Marcelli M, Reeves R, Foreyt J & Balasubramanyam A. Rise of plasma ghrelin with weight loss is not sustained during weight maintenance. Obesity 2006 14 1716-1723.
48. Lejeune MP, Hukshorn CJ, Saris WH & Westerterp-Plantenga MS. Effects of very low calorie diet induced body weight loss with or without human pegylated recombinant leptin treatment on changes in ghrelin and adiponectin concentrations. Physiology and Behavior 2007 91 274-280.
49. Kraemer RR & Castracane VD. Exercise and Immoral mediators of peripheral energy balance: ghrelin and adiponectin. Experimental Biology and Medicine 2007 232 184-194.
50. Mackelvie KJ, Meneilly GS, Elahi D, Wong AC, Barr SI & Chanoine JP. Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin. Journal of Clinical Endocrinology and Metabolism 2007 92 648-654.
51. Foster-Schubert KE, McTiernan A, Frayo RS, Schwartz RS, Rajan KB, Yasui Y, Tworoger SS & Cummings DE. Human plasma ghrelin levels increase during a one-year exercise program. Journal of Clinical Endocrinology and Metabolism 2005 90 820-825.
52. Kim HJ, Lee S, Kim TW, Kim HH, Jeon TY, Yoon YS, Oh SW, Kwak H & Lee JG. Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children. Clinical Endocrinology, 2007 (In Press).
53. Kolehmainen M, Salopuro T, Schwab US, Kekäläinen J, Kallio F, Laaksonen DE, Pulkkinen L, Lindi VI, Sivenius K, Mager U, Siitonen N, Niskanen L, Gylling H, Rauramaa R & Uusitupa M. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. International Journal of Obesity 2007 (In Press).
54. Sarkkinen E, Schwab U, Niskanen L, Hannuksela M, Savolainen M, Kervinen K, Kesäniemi A & Uusitupa MI. The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. European Journal of Clinical Nutrition 1996 50 592-598.
55. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM & Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technology & Therapeutics 2003 5 1003-1015.
56. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE & Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001 50 1714-1719.
57. Eady JJ, Wortley GM, Wormstone YM, Hughes JC, Astley SB, Foxall RJ, Doleman JF & Elliott RM. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiological Genomics 2005 22 402-411.
58. Li WG, Gavrila D, Liu X Wang L, Gunnlaugsson S, Stoll LL, McCormick ML, Sigmund CD, Tang C & Weintraub NL. Ghrelin inhibits proinflammatory responses and nuclear factor-ΚB activation in human endothelial cells. Circulation 2004 109 2221-2226.
59. Leung PK, Chow KB, Lau PN, Chu KM, Chan CB, Cheng CH & Wise H. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cellular Signalling 2007 19 1011-1022.
60. Briatore L, Andraghetti G & Cordera R. Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. European Journal of Endocrinology 2003 149 403-406.
61. Caixas A, Bashore C, Nash W. Pi-Sunyer F & Laferrere B. Insulin. unlike food intake, does not suppress ghrelin in human subjects. Journal of Clinical Endocrinology and Metabolism 2002 87 1902.
62. Schaller G, Schmidt A, Pleiner J, Woloszczuk W Wolzt M & Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 2003 32 16-20.
63. Broglio F. Arvat E, Benso A, Gotlero C, Muccioli G, Papotti M, van der Lely AJ, Deghenghi R & Ghigo E. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 5083-5086.
64. Broglio F. Gottero C, Benso A, Prodam F, Destefanis S, Gauna C, Maccarin M, Deghenghi R, van der Lely AJ & Ghigo E. Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. Journal of Clinical Endocrinology and Metabolism 2003 88 4268-4272.
65. Gauna C, Meyler FM, Janssen JA, Delhanty PJ, Abribat T, van Koetsveld P, Holland LJ, Broglio F, Ghigo E & van der Lely AJ. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2004 89 5035-5042.
66. Anderwald C, Brabant G, Bernroider E, Horn R, Brehm A, Waldhausl W & Roden M. Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 2003 52 1792-1798.
67. Gauna C. Delhanty PJ, Holland LJ. Janssen JA, Broglio F, Ross RJ, Ghigo E & van der Lely AJ. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. Journal of Clinical Endocrinology and Metabolism 2005 90 1055-1060.
68. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, Van Der Lely AJ & Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism 2004 89 3062-3065.